No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target
Purple Biotech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/11/2024 2399.38% HC Wainwright & Co. $10 → $10 Reiterates Buy → Buy 05/21/2024 2399.38% HC Wainwright &
Promising Phase 2 Results for Purple Biotech's CM24 in Pancreatic Cancer Treatment Bolster Buy Rating
Purple Biotech Unveils Incentive for Warrant Holders
Purple Biotech Secures $2 Million From Warrants
Why Purple Biotech (PPBT) Shares Are Trading Lower
Purple Biotech Ltd – ADR (NASDAQ:PPBT) shares are trading lower by 11.5% to $0.37 during Monday's session after the company announced the exercise of warrants for $2 million gross proceeds.What Happen